Clinical Trials Insight: 700026794
Phase of Trial: Phase I
Latest Information Update: 13 May 2008
At a glance
- Drugs Tezampanel (Primary)
- Indications Anxiety disorders; Cancer pain; Epilepsy; Migraine; Neuromuscular disorders; Pain; Postoperative pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors TorreyPines Therapeutics Inc
- 13 May 2008 Status changed to completed, according to a ToreyPines media release.
- 05 Feb 2008 Results reported in a TorreyPines media release.
- 06 Sep 2007 New trial record.